Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice

Do transmembrane domain neuregulin 1 mutant mice exhibit a reliable sensorimotor gating deficit?

(2011) T. Karl et al.   BEHAVIOURAL BRAIN RESEARCH

Effect of cannabidiol in a MK-801-rodent model of aspects of Schizophrenia

(2011) Anand Gururajan et al.   BEHAVIOURAL BRAIN RESEARCH

Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients

(2011) Mateus M Bergamaschi et al.   NEUROPSYCHOPHARMACOLOGY

Plasma and brain pharmacokinetic profile of cannabidiol (CBD), cannabidivarine (CBDV), Δ9-tetrahydrocannabivarin (THCV) and cannabigerol (CBG) in rats and mice following oral and intraperitoneal administration and CBD action on obsessive–compulsive behaviour

(2011) Serena Deiana et al.   PSYCHOPHARMACOLOGY

Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma

(2010) Erin L. Karschner et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids

(2010) Aurélie A. Boucher et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cognition in transmembrane domain neuregulin 1 mutant mice

(2010) L. Duffy et al.   NEUROSCIENCE

Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L.

(2010) Abir T. El-Alfy et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

A follow-up study: acute behavioural effects of Δ9-THC in female heterozygous Neuregulin 1 transmembrane domain mutant mice

(2010) Leonora E. Long et al.   PSYCHOPHARMACOLOGY

The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors

(2010) Felipe V. Gomes et al.   PSYCHOPHARMACOLOGY

Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing

(2009) Paolo Fusar-Poli et al.   ARCHIVES OF GENERAL PSYCHIATRY

Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors

(2009) TV Zanelati et al.   BRITISH JOURNAL OF PHARMACOLOGY

Reintoxication: the release of fat-stored Δ9-tetrahydrocannabinol (THC) into blood is enhanced by food deprivation or ACTH exposure

(2009) N Gunasekaran et al.   BRITISH JOURNAL OF PHARMACOLOGY

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis

(2009) Dagmar Koethe et al.   BRITISH JOURNAL OF PSYCHIATRY

Neuregulin 1 hypomorphic mutant mice: enhanced baseline locomotor activity but normal psychotropic drug-induced hyperlocomotion and prepulse inhibition regulation

(2009) Maarten van den Buuse et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

A behavioural comparison of acute and chronic Δ9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice

(2009) Leonora E. Long et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia

(2009) Glenn Schwarcz et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology

(2009) Sagnik Bhattacharyya et al.   NEUROPSYCHOPHARMACOLOGY

The effects of antipsychotic drugs administration on 5-HT1A receptor expression in the limbic system of the rat brain

(2009) M. Han et al.   NEUROSCIENCE

Cannabidiol reverses the reduction in social interaction produced by low dose Δ9-tetrahydrocannabinol in rats

(2009) Daniel Thomas Malone et al.   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Decreased density of serotonin 2A receptors in the superior temporal gyrus in schizophrenia-a postmortem study

(2009) Kai Kang et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The endocannabinoid system as a target for modelling psychosis

(2009) Dagmar Koethe et al.   PSYCHOPHARMACOLOGY

Cannabis potency and contamination: a review of the literature

(2008) Jennifer McLaren et al.   ADDICTION

Neurotoxic lesions of retrosplenial cortex disrupt signaled and unsignaled contextual fear conditioning.

(2008) Christopher S. Keene et al.   BEHAVIORAL NEUROSCIENCE

Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats

(2008) Alline Cristina Campos et al.   PSYCHOPHARMACOLOGY

The orphan receptor GPR55 is a novel cannabinoid receptor

(2007) E Ryberg et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro

(2007) A Thomas et al.   BRITISH JOURNAL OF PHARMACOLOGY

Disruption to social dyadic interactions but not emotional/anxiety-related behaviour in mice with heterozygous ‘knockout’ of the schizophrenia risk gene neuregulin-1

(2007) Colm M.P. O'Tuathaigh et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Increased levels of serotonin2A receptors and serotonin transporter in the CNS of neuregulin 1 hypomorphic/mutant mice

(2007) Brian Dean et al.   SCHIZOPHRENIA RESEARCH